Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2006 (Vol. 26, No. 4)

Blood Coagulation

URL:tollefsen.wustl.edu/projects/coagulation/coagulation.html
  • Well designed for researchers
  • Could have better educational content
In the general biochemistry course I teach at Oregon State University, one of the topics students find both fascinating and complex is that of blood coagulation. It's not without good reason, in my humble opinion. Consider the process, which results from the convergence of two interconnected, cascading pathways (intrinsic and extrinsic) giving rise to a tremendous amplification of a signal. An intelligent site that presents this complicated information in an easy to understand format is needed. Doug Tollefsen's Blood Coagulation site at Washington University in St. Louis is a step in the right direction. With well-written descriptions and updated perspectives, the site provides an excellent overview of the process from a researcher's point of view. That's all good, of course, but I'm still looking for a site with a simpler treatment for teaching the process to newbies.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »